Indaptus Therapeutics Reveals FY Financial Results
Thursday, 14 March 2024, 14:09
Indaptus Therapeutics Financial Report
Indaptus Therapeutics has released its financial results for the fiscal year. The company reported a GAAP EPS of -$1.83 and disclosed $13.4 million in cash and cash equivalents as of December 31, 2023.
Key Highlights:
- GAAP EPS: -$1.83
- Cash and Cash Equivalents: $13.4 million
The revealed figures provide insights into the financial standing of Indaptus Therapeutics and offer a glimpse into the challenges the company may face in the future.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.